Type 2 Diabetes And Obesity Research - ZenBio, Inc. Awarded $1.38 Million Phase II SBIR Grant For Skeletal Muscle Program

ZenBio, Inc. announced that it has been awarded a Phase II SBIR grant to commercialize their primary human skeletal myocyte and adipocyte co-culture system. The $1.38 million award from the National Institutes of Health will fund the continued optimization and commercial development of this unique tool for type 2 diabetes and obesity research.

More: continued here

Filed under: Diabetes on October 3rd, 2008